PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
ANGPT2 105 Target Disease Down Syndrome 10,290 1 0.00 -1.00 0.01 0.60
ANGPT2 105 Target Disease Brain Tumors 16,749 2 0.00 -0.99 0.02 0.60
ANGPT2 105 Target Disease Breast Cancer 173,695 2 0.00 -0.99 0.02 0.55
ANGPT2 105 Target Disease Leukemia 162,805 1 0.00 -1.00 0.01 0.53
ANGPT2 105 Target Target ERBB4 994 1 0.00 -0.99 0.01 0.67
ANGPT2 105 Target Disease Diabetic Retinopathy 14,494 1 0.00 -1.00 0.01 0.59
ANGPT2 105 Target Target BTK 1,263 2 0.01 -0.99 0.02 0.68
ANGPT2 105 Target Target Renin 43,456 1 0.00 -1.00 0.01 0.56
ANGPT2 105 Target Target EGF 27,487 1 0.00 -1.00 0.01 0.57
ANGPT2 105 Target Disease Inflammation 252,734 8 0.00 -0.96 0.08 0.57
ANGPT2 105 Target Target BMP-2 3,889 1 0.00 -1.00 0.01 0.62
ANGPT2 105 Target Target CD34 24,598 3 0.00 -0.99 0.03 0.60
ANGPT2 105 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.01 0.54
ANGPT2 105 Target Disease Contraception 21,402 1 0.00 -1.00 0.01 0.58
ANGPT2 105 Target Disease Glioblastoma 17,933 3 0.00 -0.99 0.03 0.61
ANGPT2 105 Target Disease Infertility 35,448 1 0.00 -1.00 0.01 0.57
ANGPT2 105 Target Target CYR61 539 3 0.01 -0.98 0.03 0.73
ANGPT1 81 Target Disease Benign Prostatic Hyperplasia 10,026 1 0.00 -0.99 0.01 0.60
ANGPT1 81 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.99 0.01 0.60
ANGPT1 81 Target Disease Arthritis 128,324 1 0.00 -0.99 0.01 0.54
ANGPT1 81 Target Disease Renal Failure 73,993 1 0.00 -0.99 0.01 0.56
ANGPT1 81 Target Target BMP-2 3,889 1 0.00 -0.99 0.01 0.63
ANGPT1 81 Target Target EPHB2 385 1 0.01 -0.99 0.01 0.70
ANGPT1 81 Target Target Phospholipase A2 13,400 1 0.00 -0.99 0.01 0.60
ANGPT1 81 Target Target ERK1 18,374 1 0.00 -0.99 0.01 0.59
ANGPT1 81 Target Disease Osteoporosis 46,215 1 0.00 -0.99 0.01 0.57
ANGPT1 81 Target Target ANGPTL4 289 3 0.02 -0.98 0.04 0.75
ANGPT1 81 Target Target CCL5 2,002 1 0.00 -0.99 0.01 0.65
ANGPT1 81 Target Target EPHB4 329 1 0.01 -0.99 0.01 0.71
ANGPT1 81 Target Disease Stroke 146,992 2 0.00 -0.99 0.02 0.56
ANGPT1 81 Target Target CCL2 3,560 1 0.00 -0.99 0.01 0.63
ANGPT1 81 Target Target EGF 27,487 2 0.00 -0.99 0.02 0.60
ANGPT1 81 Target Target ANGPT2 105 42 0.46 -0.54 0.52 0.94
ANGPT1 81 Target Disease Dyslipidemia 15,225 1 0.00 -0.99 0.01 0.59
ANGPT1 81 Target Disease Glioblastoma 17,933 1 0.00 -0.99 0.01 0.59
ANGPT1 81 Target Target Renin 43,456 1 0.00 -0.99 0.01 0.57
ANGPT1 81 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.99 0.01 0.55
ANGPT1 81 Target Disease Sepsis 64,798 1 0.00 -0.99 0.01 0.56
ANGPT1 81 Target Target BMPR1A 279 1 0.01 -0.99 0.01 0.71
ANGPT1 81 Target Disease Leukemia 162,805 1 0.00 -0.99 0.01 0.54
ANGPT1 81 Target Target Endoglin 1,333 1 0.00 -0.99 0.01 0.66
ANGPT1 81 Target Target bFGF 9,327 2 0.00 -0.99 0.02 0.62
ANGPT1 81 Target Disease Hyperlipidemia 15,317 1 0.00 -0.99 0.01 0.59
ANGPT1 81 Target Target CD34 24,598 4 0.00 -0.97 0.05 0.62
ANGPT1 81 Target Target Cox-2 21,583 2 0.00 -0.99 0.02 0.60
ANGPT1 81 Target Disease Inflammation 252,734 7 0.00 -0.96 0.09 0.57
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
AMY2B 21 Target Target AMY1A 13 2 0.12 -0.87 0.15 0.87
AMY2B 21 Target Target APOA2 118 1 0.02 -0.97 0.05 0.76
AMY2B 21 Target Target Alpha-Amylase 7,171 9 0.02 -0.76 0.43 0.70